Skip to main content
Top
Published in: Acta Diabetologica 2/2009

01-06-2009 | Short Communication

Cardiometabolic risk and educational level in adult patients with type 1 diabetes

Authors: J. Nádas, Z. Putz, J. Fövényi, Z. Gaál, A. Gyimesi, T. Hídvégi, N. Hosszúfalusi, G. Neuwirth, T. Oroszlán, P. Pánczél, G. Vándorfi, G. Winkler, I. Wittmann, G. Jermendy

Published in: Acta Diabetologica | Issue 2/2009

Login to get access

Abstract

A low educational level and a poor socioeconomic status could be associated with increased risk for chronic diseases. The aim of the study was to evaluate the relationship between the educational level and cardiometabolic risk in adult patients with type 1 diabetes (n = 437; age: 38.0 ± 10.4 years, duration of diabetes: 19.2 ± 11.1 years; x ± SD). Educational levels were classified as low [primary school, n = 56 (12.8%)], middle [high school, n = 251 (57.4%)] or high [university, n = 130 (29.7%)]. The prevalence rate of the metabolic syndrome proved to be higher in patients with low versus high educational levels (ATP-III criteria: 42.9 vs. 21.5%, P = 0.0006). Antihypertensive treatment and cardiovascular diseases were more prevalent in patients with low versus high educational level (46.4 vs. 26.2%, P = 0.01; 12.5 vs. 2.3%, P = 0.02; respectively). Overall glycemic control was worse in patients with low versus high educational level (HbAlc: 8.8 ± 1.6 vs. 7.9 ± 1.4%; P = 0.0006). Patients with low versus high educational level differed significantly regarding smoking habits (smokers: 28.6 vs. 11.6%; P = 0.01) and regular physical activity (5.4 vs. 33.1%; P = 0.0001). Higher prevalence rate of certain cardiometabolic risk factors was associated with low educational level in middle-aged type 1 diabetic patients with relatively long duration of diabetes; therefore, these patients should have priority when preventing cardiovascular complications.
Literature
1.
go back to reference Kaplan GA, Keil JE (1993) Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 88:1973–1998PubMed Kaplan GA, Keil JE (1993) Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 88:1973–1998PubMed
2.
go back to reference Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K (1999) Education and the metabolic syndrome in women. Diabetes Care 22:1999–2003PubMedCrossRef Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K (1999) Education and the metabolic syndrome in women. Diabetes Care 22:1999–2003PubMedCrossRef
3.
go back to reference Kerényi Z, Tabák AG, Stella P, Bosnyák Z, Simon K, Karádi I, Tamás G (2000) Association between socioeconomic factors and the metabolic syndrome in women with prior gestational diabetes mellitus. Diabetes Care 23:1444–1445PubMedCrossRef Kerényi Z, Tabák AG, Stella P, Bosnyák Z, Simon K, Karádi I, Tamás G (2000) Association between socioeconomic factors and the metabolic syndrome in women with prior gestational diabetes mellitus. Diabetes Care 23:1444–1445PubMedCrossRef
4.
go back to reference Maty SC, Everson-Rose SA, Haan MN, Raghunathan TE, Kaplan GA (2005) Education, income, occupation, and the 34-year incidence (1965–1999) of Type 2 diabetes in the Alameda County study. Int J Epidemiol 34:1274–1281PubMedCrossRef Maty SC, Everson-Rose SA, Haan MN, Raghunathan TE, Kaplan GA (2005) Education, income, occupation, and the 34-year incidence (1965–1999) of Type 2 diabetes in the Alameda County study. Int J Epidemiol 34:1274–1281PubMedCrossRef
5.
go back to reference Hidvégi T, Hetyési K, Bíró L, Gy Jermendy (2001) Education level and clustering of clinical characteristics of metabolic syndrome. Diabetes Care 24:2013–2014PubMedCrossRef Hidvégi T, Hetyési K, Bíró L, Gy Jermendy (2001) Education level and clustering of clinical characteristics of metabolic syndrome. Diabetes Care 24:2013–2014PubMedCrossRef
6.
go back to reference Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) JAMA 285:2486–2497 Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) JAMA 285:2486–2497
7.
go back to reference Hassan K, Loar R, Anderson BJ, Heptulla RA (2006) The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr 149:526–531PubMedCrossRef Hassan K, Loar R, Anderson BJ, Heptulla RA (2006) The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr 149:526–531PubMedCrossRef
8.
go back to reference Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Taskinen MR, Groop PH, FinnDiane Study Group (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024 Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Taskinen MR, Groop PH, FinnDiane Study Group (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024
9.
go back to reference Ball K, Crawford D (2005) Socioeconomic status and weight change in adults: a review. Soc Sci Med 60:1987–2010PubMedCrossRef Ball K, Crawford D (2005) Socioeconomic status and weight change in adults: a review. Soc Sci Med 60:1987–2010PubMedCrossRef
10.
go back to reference Davis TM, Bruce DG, Davis WA (2007) Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle diabetes study. Diabetes Res Clin Pract 78:412–417PubMedCrossRef Davis TM, Bruce DG, Davis WA (2007) Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle diabetes study. Diabetes Res Clin Pract 78:412–417PubMedCrossRef
Metadata
Title
Cardiometabolic risk and educational level in adult patients with type 1 diabetes
Authors
J. Nádas
Z. Putz
J. Fövényi
Z. Gaál
A. Gyimesi
T. Hídvégi
N. Hosszúfalusi
G. Neuwirth
T. Oroszlán
P. Pánczél
G. Vándorfi
G. Winkler
I. Wittmann
G. Jermendy
Publication date
01-06-2009
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2009
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0065-4

Other articles of this Issue 2/2009

Acta Diabetologica 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.